Table VI.
Univariate Cox regression | Multivariate Cox regression | |||||
---|---|---|---|---|---|---|
Variables | P-value | HR | 95% CI | P-value | HR | 95% CI |
Risk score (high/low) | 0.009a | 4.883 | 1.485–16.051 | 0.002a | 2.895 | 1.491–5.621 |
Age (>60/≤60) | 0.064 | 2.343 | 0.952–5.767 | |||
BMI | 0.255 | |||||
<25 | Reference | |||||
≥25 | 0.533 | 0.092–3.074 | ||||
Not reported | 0.087 | 0.004–1.772 | ||||
Race | 0.403 | |||||
Non-Asian | Reference | |||||
Asian | 4.064 | 0.514–32.105 | ||||
Not reported | 1.065 | 0.034–33.341 | ||||
Sex (Male/Female) | 0.680 | 1.523 | 0.207–11.220 | |||
Hepatitis B or C | 0.210 | |||||
No | Reference | |||||
Yes | 3.102 | 0.528–18.223 | ||||
Cirrhosis | 0.340 | |||||
Non-cirrhosis | Reference | |||||
Cirrhosis | 2.228 | 0.297–16.737 | ||||
Not reported | 0.291 | 0.037–2.284 | ||||
Histologic grade | 0.489 | |||||
G1-2 | Reference | |||||
G3-4 | 0.705 | 0.262–1.899 | ||||
New tumor event | 0.860 | |||||
No | Reference | |||||
Yes | 316078 | 0.000–3.495×1066 | ||||
Pathologic stage | 0.464 | |||||
Stage I+II | Reference | |||||
Stage III+IV | 1.896 | 0.638–5.632 | ||||
Not reported | 0.997 | 0.127–7.803 | ||||
Cancer status | 0.286 | |||||
Tumor free | Reference | |||||
With tumor | 2.632 | 0.323–21.431 | ||||
Not reported | 11.747 | 0.399–345.797 | ||||
Family cancer history | 0.242 | |||||
No | Reference | |||||
Yes | 0.726 | 0.147–3.588 | ||||
Not reported | 0.129 | 0.010–1.703 | ||||
Residual tumor | 0.749 | |||||
R0 | Reference | |||||
Non-R0 | 0.930 | 0.090–9.614 | ||||
Not reported | 0.321 | 0.015–6.981 | ||||
Vascular invasion | 0.039a | 0.001a | ||||
Negative | Reference | Reference | ||||
Positive | 10.023 | 1.408–71.326 | 2.398 | 1.104–5.210 | ||
Not reported | 3.990 | 0.369–43.169 | 4.732 | 2.235–10.019 |
P<0.05. BMI, Body mass index; AFP, α fetoprotein; HR, Hazard ratio; CI, Confidence interval.